NMI Holdings reports Q2 results today against a backdrop where options positioning tells the clearest story: call buyers have decisively taken control heading into the print.
The put/call ratio has collapsed to 0.13, more than 1.25 standard deviations below its 20-day average of 0.35 and close to the lowest reading of the past year. That is a strikingly bullish lean in the options market, suggesting traders are positioning for upside rather than reaching for downside protection. The stock itself has added 4.5% on the week to $43.44, despite pulling back 2% on Thursday — a move that matched the broader weakness in mortgage insurance peers, with ESNT off 2.4% and RDN down 2.3% on the same session.
Short interest is a quiet sideshow here. At 2.7% of the free float — down roughly 9% on the week — bears are trimming rather than pressing. Borrow conditions confirm the same read: cost to borrow has fallen nearly 44% over the past month to just 0.31%, and availability is essentially unconstrained at the maximum tracked level. There is no squeeze dynamic and no crowded short to unwind.
The analyst community has turned more constructive in the run-up. JP Morgan raised its target to $48 on July 13, maintaining Overweight, and the mean consensus target is now $47.67 — about 10% above the current price. RBC initiated coverage in May with an Outperform and a $46 target. Barclays is the lone holdout on the sidelines with an Equal-Weight. The bull case rests on NIW growth, high persistency, and rising investment income. Bears counter with the deceleration in reserve releases and a declining return on equity — 17.5% in the most recent quarter versus 19.4% previously — as signals that the profitability peak may be behind the company. The EV/EBIT multiple ranks in the 83rd percentile of the ORTEX universe, leaving little room for a miss to be absorbed without a re-rating.
One institutional data point worth noting: American Century added 249,562 shares in the most recent quarter, and Fidelity's FMR LLC added nearly 300,000 — both meaningful additions for mid-size holders. BlackRock holds 16.9% of shares, anchoring the register. Insider flows run the other way: the founder and Executive Chairman sold roughly $4.1 million of stock in March, and the CFO sold smaller amounts in May. Those sales came at prices well below today's level, so the significance is limited, but no insider has been a buyer in the window reported.
The print will test whether the momentum in new insurance written and investment income is enough to satisfy a market that has priced in a notably optimistic outcome — and whether the bear case on reserve releases and ROE compression has any traction against a stock trading near its analyst consensus target.
See the live data behind this article on ORTEX.
Open NMIH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
